Preclinical medications screening in dependence MO

This pre-solicitation notice seeks capability statements for preclinical medications screening services in dependence models of alcohol use disorder. The National Institute on Child Health and Human Development will assess statements to identify contractors qualified to test up to five compounds per year in standardized mice models at their facilities. Contractors must demonstrate experience assessing compound effects in models of elevated alcohol intake and withdrawal, collecting and analyzing test data, and reporting results. Capability statements are due by March 7, 2024 and shall not exceed 10 single-sided pages.

There is no set-aside designation for this procurement. The NAICS code is 541715 with a size standard of 1,000 employees. The statement of work outlines a base period of one year starting August 16, 2024 to test up to five compounds annually, with four optional one-year extension periods through August 15, 2029. The incumbent contracts with the Medical University of South Carolina and Indiana University for these services expire in mid-2024 and late 2024 respectively. Contractors will submit evaluation reports within 30 days of completing each test and an annual progress report by the expiration date of each optional period.